European Society of Hypertension-ESH Education-ESH Meeting Highlights 2006,index

<%@language="vbscript"%> <%'option explicit dim arr, pag dim nome_giorno_settimana(6), mese(11) nome_giorno_settimana(0) = "domenica" nome_giorno_settimana(1) = "lunedì" nome_giorno_settimana(2) = "martedì" nome_giorno_settimana(3) = "mercoledì" nome_giorno_settimana(4) = "giovedì" nome_giorno_settimana(5) = "venerdì" nome_giorno_settimana(6) = "sabato" mese(0) = "gennaio" mese(1) = "febbraio" mese(2) = "marzo" mese(3) = "aprile" mese(4) = "maggio" mese(5) = "giugno" mese(6) = "luglio" mese(7) = "agosto" mese(8) = "settembre" mese(9) = "ottobre" mese(10) = "novembre" mese(11) = "dicembre" %> European Society of Hypertension-ESH Education-ESH Meeting Highlights 2006,index

Educational Session - Renin-angiotensin system blockade as a basis for combination therapy
Supported by an unrestricted educational grant from AstraZeneca

Chairpersons: S.E. Kjeldsen (Oslo, Norway) and P.M. Nilsson (Malmo, Sweden)

Burden of hypertension and current levels of treatment and blood pressure control
G. Mancia (Milan, Italy)

[WEBCAST]

Strategies for fixed combinations, what do guidelines say?
S.E. Kjeldsen (Oslo, Norway)

[WEBCAST]

Should RAS blockade be an integral part in most combinations?
P. Trenkwalder (Starnberg, Germany)

[WEBCAST]

Dual blockade in cardiovascular disease - when is this successful?
P.A. Meredith (Glasgow, UK)

[WEBCAST]

<< back